PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8637934

The cardiopulmonary system and movement dysfunction.

C Peel
View original source ↗Export metadata ↓

Abstract

Physical therapy primarily involves the identification and treatment of problems related to movement. Movement dysfunction usually is attributed to impairments of the neuromuscular and musculoskeletal systems. The cardiopulmonary system plays an important role in movement because of its function of transporting oxygen to skeletal muscle. Abnormalities of the cardiovascular and pulmonary systems can produce limitations in physical function. The purposes of this article are to describe the steps involved in the transfer of oxygen from atmospheric air to skeletal muscles and to provide examples of problems that can occur with each step of the process. Common signs and symptoms of potential problems involving the cardiovascular and pulmonary systems also will be discussed.

Explore related subjects

Cardiovascular SystemEnergy MetabolismExerciseHumansMovement DisordersMuscle ContractionMuscle, SkeletalOxygen ConsumptionRespiratory SystemJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C Peel. 1996. The cardiopulmonary system and movement dysfunction.. https://doi.org/10.1093/ptj%2F76.5.448

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Sleep apnoea and hypertension: role of chemoreflexes in humans.

The link between sleep apnoea and systemic hypertension in humans is well documented. However, a direct causal association between the two diseases independent of comorbidities has been difficult to establish. Comorbidities clearly play an important role in this strong relationship; however, new findings also suggest that sleep apnoea is an independent risk factor for hypertension. This relationship appears to be at least in part a result of chronically elevated sympathetic activity, and therefore manifests as a neurally mediated hypertension. Although the mechanism(s) for this causal relationship of sleep apnoea to hypertension remains ill defined, a growing body of literature suggests that autonomic dysfunction, mediated by abnormal chemoreflex control of sympathetic activity, is a potential mechanism. Abnormal chemoreflex responses to both acute and chronic apnoea or hypoxia have been demonstrated. Hypothesized mechanisms by which chemoreflex dysfunction may contribute to chronically elevated sympathetic tone and ultimately hypertension are explored in this review. Thus, this review focuses on the current evidence linking chemoreflex function to obstructive sleep apnoea and systemic hypertension in humans and provides an analysis of these data and their implications.

Cardiovascular System↗
PubMed2006

Gender differences in drug responses.

This review summarizes gender differences (GDs) in drug response. Although GDs have been described both in pharmacodynamics and pharmacokinetics, their role in clinical practice is not yet completely elucidated. The evidence that women have been less enrolled in clinical trials and that a gender-specific analysis usually is not included in the evaluation of results, contributes largely to this uncertainty. Consequently, adverse drug reactions (ADRs) are still higher in females than in males. Since sex is a fundamental biological variable that cannot be discounted, GDs in pharmacology have to be considered in order to improve drug safety efficacy and to optimize medical therapy both in men and women.

Cardiovascular System↗